PNC Financial Services Group’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-20,000
Closed -$24.4K 4974
2025
Q1
$24.4K Hold
20,000
﹤0.01% 3457
2024
Q4
$25.8K Buy
+20,000
New +$47.9K ﹤0.01% 3413
2023
Q4
Sell
-56,184
Closed -$108K 4680
2023
Q3
$108K Hold
56,184
﹤0.01% 2525
2023
Q2
$80.9K Hold
56,184
﹤0.01% 2770
2023
Q1
$118K Hold
56,184
﹤0.01% 2470
2022
Q4
$63.5K Hold
56,184
﹤0.01% 2838
2022
Q3
$92K Hold
56,184
﹤0.01% 2588
2022
Q2
$74K Hold
56,184
﹤0.01% 2764
2022
Q1
$90K Buy
56,184
+10,000
+22% +$19.4K ﹤0.01% 2772
2021
Q4
$96K Hold
46,184
﹤0.01% 2716
2021
Q3
$179K Sell
46,184
-345
-0.7% -$1.17K ﹤0.01% 2267
2021
Q2
$149K Buy
46,529
+345
+0.7% +$1.23K ﹤0.01% 2409
2021
Q1
$100K Hold
46,184
﹤0.01% 2578
2020
Q4
$103K Sell
46,184
-21,784
-32% -$57.2K ﹤0.01% 2462
2020
Q3
$181K Hold
67,968
﹤0.01% 1994
2020
Q2
$208K Hold
67,968
﹤0.01% 1903
2020
Q1
$133K Hold
67,968
﹤0.01% 2046
2019
Q4
$194K Hold
67,968
﹤0.01% 2089
2019
Q3
$249K Buy
67,968
+3,000
+5% +$10.8K ﹤0.01% 2009
2019
Q2
$270K Buy
64,968
+17,804
+38% +$77.1K ﹤0.01% 1981
2019
Q1
$241K Hold
47,164
﹤0.01% 2034
2018
Q4
$162K Hold
47,164
﹤0.01% 2178
2018
Q3
$283K Sell
47,164
-5,000
-10% -$27.5K ﹤0.01% 2002
2018
Q2
$332K Buy
52,164
+980
+2% +$4.77K ﹤0.01% 1893
2018
Q1
$243K Hold
51,184
﹤0.01% 2056
2017
Q4
$171K Buy
+51,184
New +$129K ﹤0.01% 2280
2016
Q3
Sell
-200
Closed 4091
2016
Q2
$0 Buy
+200
New +$293 ﹤0.01% 4513
2015
Q4
Sell
-317
Closed -$1K 4503
2015
Q3
$1K Hold
317
﹤0.01% 4458
2015
Q2
$1K Buy
317
+135
+74% +$407 ﹤0.01% 4546
2015
Q1
$1K Buy
+182
New +$650 ﹤0.01% 4479

Other funds holding GALT